However, it remains undetermined by which mechanism the PKR pathway can independently induce RAN translation and to what extent metformin and other PKR inhibitors would be viable therapeutic options for patients with C9ORF72 ALS/FTD. This evidence concerns the gene RAN and amyotrophic lateral sclerosis.